| Model Number |
MCS-P4-23-AOA-US |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Aortic Regurgitation (1716); Regurgitation, Valvular (2335)
|
| Date of Event |
12/12/2019
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Product analysis: the valve remains implanted, therefore no product analysis can be performed.Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
Medtronic received information that approximately four years and three months following the implant of this transcatheter bioprosthetic valve, a valve-in-valve implant of new transcatheter bioprosthetic valve was performed due to aortic insufficiency.No additional adverse patient effects were reported. .
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information was received that the aortic insufficiency was severe central regurgitation.No additional adverse patient effects were reported.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Search Alerts/Recalls
|